NCT02205827View on ClinicalTrials.gov

A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy
Interventions
OTHER

Single-arm

collection of blood for assessment of whole blood clotting time

Trial Locations (1)

66211

Quintiles Phase I Services, LLC, Overland Park

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.

INDUSTRY

NCT02205827 - A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements | Biotech Hunter | Biotech Hunter